OBJECTIVE: to compare the effects of two different exercise programmesafter hip fracture. DESIGN: assessor-blinded randomised controlled trial. SETTING: hospital rehabilitation units, with continued intervention at home. SUBJECTS:160 people with surgical fixation for hip fracture transferred to inpatient rehabilitation. METHOD: in addition to other rehabilitation strategies, the intervention group received a higher dose (60 min/day) exercise programme conducted whilst standing and the control group received a lower dose exercise programme (30 min/day) primarily conducted whilst seated/supine. The primary outcome measures were knee extensor muscle strength in the fractured leg and walking speed, measured at 4 and 16 weeks. RESULTS:150 participants (94% of those recruited) completed the trial. There were no differences between the groups for the two primary outcome measures. Post hoc analyses revealed increased walking speed among those in the higher dose, weight-bearing exercise group with cognitive impairment at 4 and 16 weeks. CONCLUSIONS: there was no benefit (or harm) due to the higher dose, weight-bearing exercise programme with respect to the primary outcome measures. However, people with hip fracture and cognitive impairment gained greater benefit from the higher dose programme than from the lower dose programme.
RCT Entities:
OBJECTIVE: to compare the effects of two different exercise programmes after hip fracture. DESIGN: assessor-blinded randomised controlled trial. SETTING: hospital rehabilitation units, with continued intervention at home. SUBJECTS: 160 people with surgical fixation for hip fracture transferred to inpatient rehabilitation. METHOD: in addition to other rehabilitation strategies, the intervention group received a higher dose (60 min/day) exercise programme conducted whilst standing and the control group received a lower dose exercise programme (30 min/day) primarily conducted whilst seated/supine. The primary outcome measures were knee extensor muscle strength in the fractured leg and walking speed, measured at 4 and 16 weeks. RESULTS: 150 participants (94% of those recruited) completed the trial. There were no differences between the groups for the two primary outcome measures. Post hoc analyses revealed increased walking speed among those in the higher dose, weight-bearing exercise group with cognitive impairment at 4 and 16 weeks. CONCLUSIONS: there was no benefit (or harm) due to the higher dose, weight-bearing exercise programme with respect to the primary outcome measures. However, people with hip fracture and cognitive impairment gained greater benefit from the higher dose programme than from the lower dose programme.
Authors: Benedikt J Braun; Nils T Veith; Mika Rollmann; Marcel Orth; Tobias Fritz; Steven C Herath; Jörg H Holstein; Tim Pohlemann Journal: Int Orthop Date: 2017-04-19 Impact factor: 3.075
Authors: John A Dodson; Suzanne V Arnold; Kimberly J Reid; Thomas M Gill; Michael W Rich; Frederick A Masoudi; John A Spertus; Harlan M Krumholz; Karen P Alexander Journal: Am Heart J Date: 2012-05 Impact factor: 4.749
Authors: David J Keene; Colin Forde; Thavapriya Sugavanam; Mark A Williams; Sarah E Lamb Journal: BMC Musculoskelet Disord Date: 2020-07-04 Impact factor: 2.362
Authors: B J Braun; N T Veith; S C Herath; R Hell; M Rollmann; M Orth; J H Holstein; T Pohlemann Journal: Unfallchirurg Date: 2018-04 Impact factor: 1.000
Authors: Barbara Resnick; Lauren Beaupre; Katherine S McGilton; Elizabeth Galik; Wen Liu; Mark D Neuman; Ann L Gruber-Baldini; Denise Orwig; Jay Magaziner Journal: J Am Med Dir Assoc Date: 2015-11-25 Impact factor: 4.669
Authors: Lauren A Beaupre; Ellen F Binder; Ian D Cameron; C Allyson Jones; Denise Orwig; Cathie Sherrington; Jay Magaziner Journal: Best Pract Res Clin Rheumatol Date: 2013-12 Impact factor: 4.098